Neospray 4

Hazard statements (CLP)

H314, H318, H373

Code

Statements

H314

Causes severe skin burns and eye damage

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

May cause damage to organs through prolonged or repeated exposure. Causes severe skin burns and eye damage. Causes serious eye damage.

2.2 Label elements

Labelling

Hazard pictograms

GHS05 GHS08

Signal word

Danger

Contains

CAUSTIC POTASH LIQUOR; TRISODIUM NITRILOTRIACETATE

Hazard statements

H314 - Causes severe skin burns and eye damage. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P301+P330+P331+P310 - IF SWALLOWED: rinse mouth. Do NOT induce vomiting. Immediately call a POISON CENTER or doctor. P303+P361+P353+P310 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. Immediately call a POISON CENTER or doctor. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P314 - Get medical advice/attention if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label).

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in CAUSTIC POTASH LIQUOR (1310-58-3) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605